Related content

Circulating human papillomavirus DNA as a marker for disease extent and recurrence among patients with oropharyngeal cancer

By  

Cancer, Vol. 121, Iss. 19, 2015-10 ,pp. : 3455-3464

Blackwell Publishing

Access to resources Recommend Favorite

What is the best treatment for patients with human papillomavirus–positive and –negative oropharyngeal cancer?

By Urban Damien   Corry June   Rischin Danny  

Cancer, Vol. 120, Iss. 10, 2014-05 ,pp. : 1462-1470

Blackwell Publishing

Access to resources Recommend Favorite

Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status

By Huang Shao Hui   Waldron John N.   Milosevic Michael   Shen Xiaowei   Ringash Jolie   Su Jie   Tong Li   Perez-Ordonez Bayardo   Weinreb Ilan   Bayley Andrew J.   Kim John   Hope Andrew   Cho B.C. John   Giuliani Meredith   Razak Albiruni   Goldstein David   Shi Willa   Liu Fei-Fei   Xu Wei   O'Sullivan Brian  

Cancer, Vol. 121, Iss. 4, 2015-02 ,pp. : 545-555

Blackwell Publishing

Access to resources Recommend Favorite

A cost-effectiveness analysis of human papillomavirus vaccination of boys for the prevention of oropharyngeal cancer

By Graham Donna M.   Isaranuwatchai Wanrudee   Habbous Steven   de Oliveira Claire   Liu Geoffrey   Siu Lillian L.   Hoch Jeffrey S.  

Cancer, Vol. 121, Iss. 11, 2015-06 ,pp. : 1785-1792

Blackwell Publishing

Access to resources Recommend Favorite

Low Prevalence of Human Papillomavirus (HPV) in Chinese Patients with Breast Cancer

By Mou X   Chen L   Liu F   Shen Y   Wang H   Li Y   Yuan L   Lin J   Lin J   Teng L   Xiang C  

The Journal of International Medical Research, Vol. 39, Iss. 5, 2011-09 ,pp. : 1636-1644

Field House Publishing

Access to resources Recommend Favorite